Share This Author
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
- R. Motzer, Thomas E. Hutson, R. Figlin
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 August 2009
TLDR
A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.
- A. Passaniti, R. M. Taylor, G. Martin
- Biology, MedicineLaboratory investigation; a journal of technical…
- 1992
TLDR
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
- Huafeng Zhang, D. Qian, G. Semenza
- Biology, ChemistryProceedings of the National Academy of Sciences
- 1 December 2008
TLDR
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- N. Haas, J. Manola, R. DiPaola
- MedicineThe Lancet
- 14 May 2016
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.
- D. Qian, S. Kachhap, R. Pili
- Biology, ChemistryCancer research
- 1 September 2006
TLDR
Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.
- O. Volpert, R. Pili, R. Alani
- BiologyCancer cell
- 1 December 2002
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma
- A. Orillion, A. Hashimoto, R. Pili
- Biology, MedicineClinical Cancer Research
- 11 July 2017
TLDR
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer.
- M. Carducci, L. Musib, R. Herbst
- MedicineJournal of clinical oncology : official journal…
- 1 September 2006
TLDR
Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589
TLDR
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
- K. Gotink, H. Broxterman, H. Verheul
- Biology, ChemistryClinical Cancer Research
- 6 October 2011
TLDR
...
...